As of 11 AM EST Friday morning, Nuvalent has gained over 50% on its share price. The stock topped out at around $38/share (a 75% gain) but has started to trend back downwards and currently sits at $33/share. What happened to cause this spike? The company creates precisely targeted cancer treatments designed to [...]